OasisLMS

This course reviews the rare but serious malignancies associated with breast implants, including breast implant-associated (BIA) anaplastic large-cell lymphoma, B-cell lymphoma, and squamous cell carcinoma. Participants will explore the epidemiology, clinical presentation, diagnostic evaluation, and management strategies for these implant-associated cancers, with emphasis on BIA anaplastic large-cell lymphoma as the most frequently reported subtype and BIA squamous cell carcinoma as the most aggressive.

The course highlights common presenting symptoms such as late seroma, pain, and swelling, and outlines recommended diagnostic workup, including imaging modalities and fluid aspiration with pathologic evaluation. Learners will also review current treatment approaches, including surgical excision algorithms and adjuvant therapies tailored to disease stage and subtype. This activity is designed to help surgeons recognize early warning signs, initiate appropriate evaluation, and apply evidence-based management strategies for patients with suspected breast implant-associated malignancies.

Intended Audience

This educational activity is intended for all CME-related persons including plastic surgery practitioners, residents, and other healthcare professionals.

Learning Objectives

After viewing this course, the participant should be able to:

1. Name the 3 major subtypes of breast implant–associated (BIA) malignancies.
2. Recognize the most common presenting symptoms of BIA malignancies.
3. Identify appropriate treatment options for each BIA malignancy, including chemotherapy, radiation, and surgery.
4. Answer patient questions about recurrence and reconstruction after a diagnosis of BIA malignancy.

Megan E. Fracol, MD

Roberto N. Miranda, MD

Anne S. Tsao, MD, MBA

Megan M. Rodriguez, BS

Loretta J. Nastoupil, MD

Patricia A. Young, MD

Andy E. Sherrod, MD

Danielle M. LeBlanc, MD

Lisa M. Hunsicker, MD

Carlos E. Bacchi, MD

Thiago Gabriel, MD

Terence M. Myckatyn, MD

Shoichiro Tanaka, MD

Lauren V. Kuykendall, MD

Erika Resetkova, MD

Mark G. Evans, MD

Puja Jagasia, BA

Colleen M. McCarthy, MD

Fabio Santanelli Di Pompeo, MD, PhD

Kelly K. Hunt, MD1 L. Jeffrey Medeiros, MD

Cara Haymaker, PhD

Mark W. Clemens, MD, MBA

Editor-in-Chief: Kevin Chung, MD

Co-Editor: Amy Colwell, MD

Section Editors: John Y.S. Kim, MD

• Patient Care and Procedural Skills
• Medical Knowledge
• Practice-based Learning and Improvement

Accreditation

The American Society of Plastic Surgeons (ASPS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation

The ASPS designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 CreditTM: 1.0

Media: Journal Article

Release Date: 5/8/2026

Expiration Date: 5/8/2029*

Estimated time to complete this course: 1 hour

*Course access ends on course expiration date

Disclosure Policy

The American Society of Plastic Surgeons (ASPS) requires all instructors, planners, reviewers, managers and other individuals in a position to control or influence the content of an activity to disclose all relevant financial relationships or affiliations. All identified conflicts of interest must be resolved and the educational content thoroughly vetted by ASPS for fair balance, scientific objectivity and appropriateness of patient care recommendations. ASPS also requires faculty/authors to disclose when off-label/unapproved uses of product are discussed in a CME activity or included in related materials.

Disclaimer: All relevant financial relationships for planners, faculty and others in control of content (either individually or as a group) are reviewed by the ASPS Continuing Education Committee and have been mitigated, if applicable.

The following planners/faculty members/reviewers have the following disclosures:

Dr. Evans is an employee of Caris Life Sciences (salary and travel expenses funded by Caris Life Sciences); he is not a stockholder. The MD Anderson Cancer Center participates in US FDA clinical trials for AbbVie Allergan, Mentor Corporation, and Establishment Labs. No other author has a financial disclosure or conflict of interest to report. No funding was received for ths article.

The following planners and faculty members have no relevant financial relationships or affiliations to disclose:

Megan E. Fracol, MD

Roberto N. Miranda, MD

Anne S. Tsao, MD, MBA

Megan M. Rodriguez, BS

Loretta J. Nastoupil, MD

Patricia A. Young, MD

Andy E. Sherrod, MD

Danielle M. LeBlanc, MD

Lisa M. Hunsicker, MD

Carlos E. Bacchi, MD

Thiago Gabriel, MD

Terence M. Myckatyn, MD

Shoichiro Tanaka, MD

Lauren V. Kuykendall, MD

Erika Resetkova, MD

Puja Jagasia, BA

Colleen M. McCarthy, MD

Fabio Santanelli Di Pompeo, MD, PhD

Kelly K. Hunt, MD1 L. Jeffrey Medeiros, MD

Cara Haymaker, PhD

Mark W. Clemens, MD, MBA

Editor-in-Chief: Kevin Chung, MD

Co-Editor: Amy Colwell, MD

Section Editors: John Y.S. Kim, MD

Recognition Statement

The Continuing Medical Education (CME) credits offered by this activity are enhanced by ASPS Learner Credit Reporting for learners who have opted into this reporting. Successful completion of this CME activity enables active American Board of Surgery (ABS) members the opportunity to earn credit toward the CME requirement of the ABS's Continuous Certification program when claimed within 30 days of completion of the activity.

Directly provided by the American Society of Plastic Surgeons® (ASPS®)

Participants in ASPS-accredited education who want their CME credits reported to certifying and state licensing boards must opt-in to reporting and add their NPI as well as state license ID and/or collaborating board ID(s) before claiming credit.